QI
DXCM icon

QS Investors’s DexCom DXCM Stock Holding History

QS Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.43M Buy
13,392
+1,200
+10% +$115K 0.02% 410
2021
Q1 		$1.1M Buy
12,192
+1,200
+11% +$113K 0.01% 514
2020
Q4 		$1.02M Buy
10,992
+80
+0.7% +$7.14K 0.01% 501
2020
Q3 		$1.13M Sell
10,912
-1,640
-13% -$171K 0.02% 416
2020
Q2 		$1.27M Buy
12,552
+3,752
+43% +$336K 0.02% 650
2020
Q1 		$593K Hold
8,800
– – 0.01% 797
2019
Q4 		$483K Hold
8,800
– – ﹤0.01% 948
2019
Q3 		$329K Hold
8,800
– – ﹤0.01% 1062
2019
Q2 		$330K Hold
8,800
– – ﹤0.01% 1092
2019
Q1 		$263K Sell
8,800
-28
-0.3% -$984 ﹤0.01% 1144
2018
Q4 		$265K Hold
8,828
– – ﹤0.01% 1056
2018
Q3 		$316K Sell
8,828
-2,800
-24% -$86.8K ﹤0.01% 1075
2018
Q2 		$276K Hold
11,628
– – ﹤0.01% 1106
2018
Q1 		$216K Hold
11,628
– – ﹤0.01% 1147
2017
Q4 		$167K Hold
11,628
– – ﹤0.01% 1265
2017
Q3 		$142K Hold
11,628
– – ﹤0.01% 1345
2017
Q2 		$213K Hold
11,628
– – ﹤0.01% 1186
2017
Q1 		$246K Buy
11,628
+11,600
+41,429% +$226K ﹤0.01% 1166
2016
Q4 		$1K Hold
28
– – ﹤0.01% 1581
2016
Q3 		$1K Sell
28
-145,404
-100% -$3.24M ﹤0.01% 1565
2016
Q2 		$2.88M Sell
145,432
-128,788
-47% -$2.19M 0.02% 551
2016
Q1 		$4.66M Hold
274,220
– – 0.04% 403
2015
Q4 		$5.62M Sell
274,220
-3,940
-1% -$82K 0.05% 348
2015
Q3 		$5.97M Sell
278,160
-86,988
-24% -$1.94M 0.06% 290
2015
Q2 		$7.3M Sell
365,148
-100,068
-22% -$1.76M 0.09% 274
2015
Q1 		$7.25M Sell
465,216
-76,684
-14% -$1.16M 0.08% 274
2014
Q4 		$7.46M Buy
+541,900
New +$6.63M 0.09% 268
2014
Q2 		– Sell
-373,200
Closed -$3.86M – 792
2014
Q1 		$3.86M Buy
373,200
+173,600
+87% +$1.79M 0.12% 175
2013
Q4 		$1.77M Buy
+199,600
New +$1.58M 0.07% 233

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

QS Investors's DXCM Position: Q2 2021 in Review

QS Investors increased its DexCom (DXCM) stake by 9.8% in Q2 2021, buying an estimated $115K and bringing the position to 13,392 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #410.

QS Investors first reported a position in DXCM in Q4 2013 and has held it in 29 quarters since. The position peaked at $7.46M in Q4 2014. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • QS Investors held 13,392 shares of DexCom worth $1.43M as of Q2 2021.
  • QS Investors bought 1,200 DexCom shares in Q2 2021, an estimated $115K.
  • DexCom made up 0.02% of QS Investors's portfolio in Q2 2021, its #410 holding.
  • QS Investors first reported a position in DexCom in Q4 2013 and has held it in 29 quarters since.
  • QS Investors's DexCom position peaked at $7.46M in Q4 2014.
  • 726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.